BioCardia Statistics
Share Statistics
BioCardia has 4.58M shares outstanding. The number of shares has increased by -83.8% in one year.
| Shares Outstanding | 4.58M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 92.38% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.80M |
| Failed to Deliver (FTD) Shares | 863 |
| FTD / Avg. Volume | 0.93% |
Short Selling Information
The latest short interest is 86.28K, so 1.88% of the outstanding shares have been sold short.
| Short Interest | 86.28K |
| Short % of Shares Out | 1.88% |
| Short % of Float | 2.42% |
| Short Ratio (days to cover) | 1.41 |
Valuation Ratios
The PE ratio is -1.22 and the forward PE ratio is -1.89.
| PE Ratio | -1.22 |
| Forward PE | -1.89 |
| PS Ratio | 29.48 |
| Forward PS | 19.1 |
| PB Ratio | -8.77 |
| P/FCF Ratio | -1.41 |
| PEG Ratio | n/a |
Enterprise Valuation
BioCardia Inc. has an Enterprise Value (EV) of 14.28M.
| EV / Earnings | -1.23 |
| EV / Sales | 29.94 |
| EV / EBITDA | -1.24 |
| EV / EBIT | -1.23 |
| EV / FCF | -1.43 |
Financial Position
The company has a current ratio of 0.4, with a Debt / Equity ratio of -0.21.
| Current Ratio | 0.4 |
| Quick Ratio | 0.4 |
| Debt / Equity | -0.21 |
| Total Debt / Capitalization | -26.22 |
| Cash Flow / Debt | -29.95 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 7.22% and return on capital (ROIC) is 4043.06%.
| Return on Equity (ROE) | 7.22% |
| Return on Assets (ROA) | -3.87% |
| Return on Capital (ROIC) | 4043.06% |
| Revenue Per Employee | 29.81K |
| Profits Per Employee | -723.19K |
| Employee Count | 16 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -76.94% in the last 52 weeks. The beta is 1.27, so BioCardia 's price volatility has been higher than the market average.
| Beta | 1.27 |
| 52-Week Price Change | -76.94% |
| 50-Day Moving Average | 2.37 |
| 200-Day Moving Average | 3.76 |
| Relative Strength Index (RSI) | 42.41 |
| Average Volume (20 Days) | 93.06K |
Income Statement
In the last 12 months, BioCardia had revenue of $477.00K and earned -$11.57M in profits. Earnings per share was $-8.19.
| Revenue | 477.00K |
| Gross Profit | -7.25M |
| Operating Income | -11.64M |
| Net Income | -11.57M |
| EBITDA | -11.56M |
| EBIT | -11.64M |
| Earnings Per Share (EPS) | -8.19 |
Balance Sheet
The company has $1.10M in cash and $1.31M in debt, giving a net cash position of -$212.00K.
| Cash & Cash Equivalents | 1.10M |
| Total Debt | 1.31M |
| Net Cash | -212.00K |
| Retained Earnings | -152.18M |
| Total Assets | 6.27M |
| Working Capital | 2.22M |
Cash Flow
In the last 12 months, operating cash flow was -$9.97M and capital expenditures -$12.00K, giving a free cash flow of -$9.99M.
| Operating Cash Flow | -9.97M |
| Capital Expenditures | -12.00K |
| Free Cash Flow | -9.99M |
| FCF Per Share | -7.07 |
Margins
Gross margin is -1.52K%, with operating and profit margins of -2.44K% and -2.43K%.
| Gross Margin | -1.52K% |
| Operating Margin | -2.44K% |
| Pretax Margin | -2.43K% |
| Profit Margin | -2.43K% |
| EBITDA Margin | -2.42K% |
| EBIT Margin | -2.44K% |
| FCF Margin | -2.09K% |
Dividends & Yields
BCDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -393.75% |
| FCF Yield | -104.73% |
Analyst Forecast
The average price target for BCDA is $25, which is 1101.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $25 |
| Price Target Difference | 1101.9% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on May 30, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | May 30, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -37.26 |
| Piotroski F-Score | 2 |